Date published: 2026-1-9

1-800-457-3801

SCBT Portrait Logo
Seach Input

Belinostat (CAS 414864-00-9)

5.0(1)
Write a reviewAsk a question

Alternate Names:
(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide
Application:
Belinostat is a novel HDAC inhibitor
CAS Number:
414864-00-9
Molecular Weight:
318.35
Molecular Formula:
C15H14N2O4S
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Belinostat (PXD101) is a novel HDAC inhibitor with IC50 of 27 nM. Belinostat inhibits the growth of tumor cells (A2780, HCT116, HT29, WIL, CALU-3, MCF7, PC3 and HS852) with IC50 from 0.2-0.66 μM. PD101 shows low activity in A2780/cp70 and 2780AD cells. Belinostat inhibits bladder cancer cell growth, especially in 5637 cells, which shows accumulation of G0-G1 phase, decrease in S phase, and increase in G2-M phase. Belinostat also shows enhanced tubulin acetylation in ovarian cancer cell lines. A recent study shows that Belinostat activates protein kinase A in a TGF-β signaling-dependent mechanism and decreases survivin mRNA.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Belinostat, 10 mg

sc-269851
10 mg
$156.00

Belinostat, 100 mg

sc-269851A
100 mg
$572.00